PE20050356A1 - Preparacion de peptidos de somatostatina - Google Patents

Preparacion de peptidos de somatostatina

Info

Publication number
PE20050356A1
PE20050356A1 PE2004000764A PE2004000764A PE20050356A1 PE 20050356 A1 PE20050356 A1 PE 20050356A1 PE 2004000764 A PE2004000764 A PE 2004000764A PE 2004000764 A PE2004000764 A PE 2004000764A PE 20050356 A1 PE20050356 A1 PE 20050356A1
Authority
PE
Peru
Prior art keywords
boc
alkylene
phg
bzl
tyr
Prior art date
Application number
PE2004000764A
Other languages
English (en)
Inventor
Heribert Hellstern
Walter Prikoszovich
Werner Pachinger
Bernhard Wietfeld
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20050356A1 publication Critical patent/PE20050356A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/02Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

REFERIDA A UN PROCEDIMIENTO PARA PRODUCIR UN COMPUESTO ANALOGO CICLICO DE SOMATOSTATINA DE FORMULA I DONDE, R1 ES ALQUILENO C2-C6-COOH, ALQUILENO C2-C6-GUANIDINA, ALQUILENO C2-C6-NH2, ENTRE OTROS; R2 ES Z1-CH2-R5, -CH-CO-O-CH2-R5, ENTRE OTROS; R5 ES FENILO OPCIONALMENTE SUSTITUIDO O UNA SAL DEL MISMO, Z1 ES O O S. SON COMPUESTOS PREFERIDOS: [H-TYR(BZL)-PHE-(2S,4R)-4-(BOC-NH-CH2-CH2-NH-CO-O)-PRO-PHG-D-TRP-LYS(BOC)-OH], RESINA DE POLIESTIRENO DE AMINOMETILO DE 4-(CLORO(DIFENIL)METIL)BENZOILO, CICLO[(2S,4R)-4-(BOC-NH-CH2-CH2-NH-CO-O)-PRO-PHG-D-TRP(BOC)-LYS(BOC)-TYR(BZL)-PHE-], ENTRE OTROS
PE2004000764A 2003-08-08 2004-08-06 Preparacion de peptidos de somatostatina PE20050356A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0318682.2A GB0318682D0 (en) 2003-08-08 2003-08-08 Organic compounds

Publications (1)

Publication Number Publication Date
PE20050356A1 true PE20050356A1 (es) 2005-06-17

Family

ID=27839906

Family Applications (2)

Application Number Title Priority Date Filing Date
PE2008001723A PE20091210A1 (es) 2003-08-08 2004-08-06 Preparacion de peptidos de somatostatina
PE2004000764A PE20050356A1 (es) 2003-08-08 2004-08-06 Preparacion de peptidos de somatostatina

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PE2008001723A PE20091210A1 (es) 2003-08-08 2004-08-06 Preparacion de peptidos de somatostatina

Country Status (35)

Country Link
US (1) US7615609B2 (es)
EP (1) EP1654280B8 (es)
JP (1) JP4580928B2 (es)
KR (1) KR101136633B1 (es)
CN (2) CN102127155B (es)
AR (1) AR045327A1 (es)
AT (1) ATE394424T1 (es)
AU (1) AU2004262570B2 (es)
BR (1) BRPI0413437B1 (es)
CA (1) CA2534224C (es)
CO (1) CO5660271A2 (es)
CY (1) CY1108775T1 (es)
DE (1) DE602004013599D1 (es)
DK (1) DK1654280T3 (es)
EC (1) ECSP066352A (es)
ES (1) ES2307039T3 (es)
GB (1) GB0318682D0 (es)
HK (1) HK1090065A1 (es)
HR (1) HRP20080350T3 (es)
IL (1) IL173272A (es)
IS (1) IS2894B (es)
MA (1) MA27982A1 (es)
MX (1) MXPA06001525A (es)
MY (1) MY141731A (es)
NO (1) NO338367B1 (es)
NZ (1) NZ544961A (es)
PE (2) PE20091210A1 (es)
PL (1) PL1654280T3 (es)
PT (1) PT1654280E (es)
RU (1) RU2360921C2 (es)
SI (1) SI1654280T1 (es)
TN (1) TNSN06045A1 (es)
TW (1) TWI345570B (es)
WO (1) WO2005014624A2 (es)
ZA (1) ZA200600584B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2225271B1 (en) * 2007-12-03 2013-07-31 ITALFARMACO S.p.A. New non-selective somatostatin analogues
EP2067786A1 (en) 2007-12-07 2009-06-10 ITALFARMACO S.p.A. Novel non selective analogs of somatostatin
ES2522167T3 (es) 2010-01-05 2014-11-13 National Dong Hwa University Formulación anticancerosa
CN103467575B (zh) * 2013-08-22 2016-03-02 深圳翰宇药业股份有限公司 一种帕西瑞肽的制备方法
CN103641894B (zh) * 2013-12-06 2015-10-28 深圳翰宇药业股份有限公司 一种治疗库欣病的多肽药物的制备方法
EP3233899B1 (en) * 2014-12-19 2020-06-24 Auro Peptides LTD A process for the preparation of pasireotide
CN106188231B (zh) * 2015-05-25 2021-10-22 中国医学科学院药物研究所 帕西瑞肽五肽中间体的合成与应用
CN114621326B (zh) * 2020-12-10 2023-12-26 武汉武药科技有限公司 门冬氨酸帕瑞肽及其中间体和其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3303345A1 (de) 1983-02-02 1984-08-02 Hoechst Ag, 6230 Frankfurt Cyclische peptide mit somatostatin-wirkung
EP0255224A3 (en) 1986-06-30 1990-04-18 Merck & Co. Inc. Cyclic and bridged cyclic somatostatin analogs useful as analgesic agents
US5811512A (en) 1991-08-22 1998-09-22 The Trustees Of The University Of Pennsylvania Non-peptide peptidomimetics and related cyclic hexapeptides
DE69426673T2 (de) 1993-06-23 2001-09-20 Diatide Inc Radiomarkierte somatostatin derivate zur abbildung und zur therapeutischen verwendung
US5770687A (en) 1995-06-07 1998-06-23 Peptor Limited Comformationally constrained backbone cyclized somatostatin analogs
US6355613B1 (en) 1996-07-31 2002-03-12 Peptor Limited Conformationally constrained backbone cyclized somatostatin analogs
GB0018891D0 (en) * 2000-08-01 2000-09-20 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
HRP20080350T3 (en) 2008-08-31
KR20060070541A (ko) 2006-06-23
US20060258838A1 (en) 2006-11-16
CY1108775T1 (el) 2014-04-09
EP1654280B1 (en) 2008-05-07
TNSN06045A1 (en) 2007-10-03
KR101136633B1 (ko) 2012-04-18
HK1090065A1 (en) 2006-12-15
RU2360921C2 (ru) 2009-07-10
CO5660271A2 (es) 2006-07-31
BRPI0413437B1 (pt) 2017-12-12
CN102127155B (zh) 2013-11-27
EP1654280B8 (en) 2008-08-13
ES2307039T3 (es) 2008-11-16
ECSP066352A (es) 2006-08-30
ZA200600584B (en) 2006-12-27
EP1654280A2 (en) 2006-05-10
PL1654280T3 (pl) 2008-10-31
MY141731A (en) 2010-06-15
IL173272A0 (en) 2006-06-11
IL173272A (en) 2012-03-29
WO2005014624A3 (en) 2005-09-22
MA27982A1 (fr) 2006-07-03
RU2006106721A (ru) 2007-09-20
MXPA06001525A (es) 2006-05-15
AR045327A1 (es) 2005-10-26
CA2534224A1 (en) 2005-02-17
DK1654280T3 (da) 2008-09-29
IS2894B (is) 2014-09-15
IS8338A (is) 2006-03-02
TW200524955A (en) 2005-08-01
PE20091210A1 (es) 2009-09-07
TWI345570B (en) 2011-07-21
US7615609B2 (en) 2009-11-10
CN1832962A (zh) 2006-09-13
DE602004013599D1 (de) 2008-06-19
AU2004262570B2 (en) 2008-06-19
BRPI0413437A (pt) 2006-10-10
ATE394424T1 (de) 2008-05-15
NO338367B1 (no) 2016-08-15
NO20061125L (no) 2006-05-08
WO2005014624A2 (en) 2005-02-17
JP2007526899A (ja) 2007-09-20
AU2004262570A1 (en) 2005-02-17
CA2534224C (en) 2012-03-27
SI1654280T1 (sl) 2008-10-31
PT1654280E (pt) 2008-08-18
JP4580928B2 (ja) 2010-11-17
CN102127155A (zh) 2011-07-20
NZ544961A (en) 2008-08-29
GB0318682D0 (en) 2003-09-10

Similar Documents

Publication Publication Date Title
ES2421447T3 (es) Métodos para proteger frente a apoptosis usando lipopéptidos
CY1108547T1 (el) Αναλογα σωματοστατινης
BRPI0417684A (pt) composto, composição farmacêutica, e, uso de um composto
MXPA06001283A (es) Derivados de insulina novedosos.
EA200701065A1 (ru) Инъецируемые составы, содержащие нанодисперсный оланзапин
HK1088840A1 (en) Stable analogs of glp-1 glp-1
DE602005008996D1 (de) Radiofluorierte peptide
NO20075927L (no) IL-21 varianter
EA200501363A1 (ru) Состав для ингалятора, выдающего мерную дозу препарата, с использованием гидрофторалканов в качестве пропеллентов
PE20050356A1 (es) Preparacion de peptidos de somatostatina
PE20080355A1 (es) Compuestos peptidicos como inhibidores de proteasa de serina del virus de hepatitis c
CO6140037A2 (es) Organismos clostridium atenuados recombinados y vacuna
TW200508219A (en) Process for preparing optically pure active compounds
DE602004004156D1 (de) Verbindungen, verfahren und formulierungen zur oralen verabreichung einer glucagon like peptide (glp)-1-verbindung oder eines am melanocortin-4-rezeptor (mc4) als agonist wirkenden peptids
ATE388695T1 (de) Pharmazeutische zusammensetzung enthaltend ein benzimidazol-derivat gemischt mit mikrokristalliner cellulose
FR2841904B1 (fr) Analogues de facteurs x clivables par la thrombine
AR038144A1 (es) Agonistas del receptor 2 del factor liberador de la corticotropina
HK1091816A1 (en) Diphenylurea derivatives and their use as chloride channel blockers
ATE409499T1 (de) Verwendung von antiseptischen wirkstoffen in pmma-knochenzementen
EA200400588A1 (ru) Линейные основные соединения, имеющие антагонистическую активность в отношении nk-2, и их композиции
ATE384066T1 (de) Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
WO2003038061A3 (en) Ehrlichia disulfide bond formation proteins and uses thereof
DE50201777D1 (de) Kristallmodifikation eines cyclischen depsipeptids mit besserer wirksamkeit
FR2837104B1 (fr) Utilisation de melange de lipopeptides pour la fabrication de vaccins
DE60308166D1 (de) Dipeptidische wachstumshormonsekretionsförderern

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed